List view / Grid view
Bristol-Myers Squibb Company and Pfizer announced that the U.S. FDA…
2 January 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Pfizer announced that the U.S. FDA approved ELIQUIS® (apixaban)...
The EC has approved ELIQUIS®...
20 November 2012 | By Bristol-Myers Squibb Company
The EC has approved ELIQUIS®...
The U.S. FDA has approved XELJANZ®...
6 November 2012 | By Pfizer
The U.S. FDA has approved XELJANZ®...
NEXIUM 20mg retail launch targeted for 2014, subject to regulatory…
13 August 2012 | By AstraZeneca
NEXIUM 20mg retail launch targeted for 2014, subject to regulatory approval...
Olivier will succeed David Simmons...
23 May 2012 | By Pfizer
Olivier will succeed David Simmons...
First pneumococcal conjugate vaccine for adults 50+ has potential to…
30 December 2011 | By Pfizer
First pneumococcal conjugate vaccine for adults 50+ has potential to help address high incidence of pneumococcal pneumonia...
Pfizer Inc. has announced that its Board of Directors has…
12 December 2011 | By Pfizer
Pfizer Inc. has announced that its Board of Directors has elected Ian Read, as Chairman of the Board and CEO, effective immediately...
Pfizer completed its acquisition of King through the merger of…
1 March 2011 | By Pfizer
Pfizer completed its acquisition of King through the merger of its wholly owned subsidiary, Parker Tennessee Corp...
